No Detail Found!

Clinical effect of qingre bawei capsules combined with budesonide in the treatment of acute exacerbation of chronic obstructive pulmonary disease

Author(s)
Yanli Sun Baoding No.1 Central Hospital, China
Huanxin Ren Baoding No.1 Central Hospital, China
Xinrong Han Baoding No.1 Central Hospital, China
Shuo Yu Baoding No.1 Central Hospital, China
Hongming An Baoding No.1 Central Hospital, China
Xixi Yang Baoding No.1 Central Hospital, China
Abstract
Objective: To assess the clinical effect of Qingre Bawei capsules combined with budesonide in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Method:The retrospective study was conducted at the Baoding No.1 Central Hospital, China, and comprised data of patients with acute exacerbation of COPD admitted between June 1, 2020, and June 30, 2022. The patients were divided into two groups based on treatment methods. The group A had been treated with Qingre Bawei capsules in combination with budesonide, while the group B had been treated with budesonide alone. Both the groups had been treated for 2 consecutive weeks. The changes in blood gas indicators, infl ammation indicators, and lung function indicators were compared between two groups of patients before and 24 hours after treatment. The time for clinical symptom disappearance and adverse reactions between the two groups of patients was also noted. Results: Of the 120 patients, 60(50%) were in group A; 41(68.3%) males and 19(31.7%) females, with mean age 65.28±4.36 years (range: 47-78 years) and mean course of disease 31.22±4.75 hours (range: 6-65 hours). 60(50%) patients were in group B; 43(71.7%) males and 17(28.3%) females with mean age 65.31±4.31 years (range: 48-78 years) and mean course of disease 31.29±4.71 hours (range: 8-68 hours). The disappearance time of clinical symptoms in group A was better than group B (p<0.05).The levels of blood gas indicators, infl ammation indicators, and lung function indicators in both groups signifi cantly improved (p<0.05), but the degree of improvement in group A was better than group B (p<0.05); The total effective rate of group A was better than group B (p<0.05). None of the patients in either group experienced any signifi cant adverse reaction. Conclusion: Qingre Bawei capsules combined with budesonide had a signifi cantly better therapeutic effect on cases of acute exacerbation of chronic obstructive pulmonary disease compared to budesonide alone.
Publication Details
Page(s) 1470-1474
Published Journal: Journal of Pakistan Medical Association, Volume: 74, Issue: 8, Year: 2024

Request the full text from PASTIC

Keywords
clinical, Chronic obstructive pulmonary disease, Acute exacerbation, Qingre Bawei capsules, Budesonide
0

Citations

0

Downloads

94

Views